Open AccessCompounded bioidentical HRT improves quality of life and reduces menopausal symptoms
Author(s) -
Vera Maria Villamil Martins,
Nick Legroux,
Monica Lascar,
Marion Gluck
Publication year - 2020
Publication title -
journal of prescribing practice
Language(s) - English
Resource type - Journals
eISSN - 2631-8393
pISSN - 2631-8385
DOI - 10.12968/jprp.2020.2.7.384
Subject(s) - hormone replacement therapy (female to male) , medicine , climacteric , quality of life (healthcare) , menopause , hormone therapy , physical therapy , gynecology , breast cancer , testosterone (patch) , cancer , nursing
Bioidentical hormone replacement therapy, a form of hormone balancing and treatment that uses hormones identical to the ones naturally produced by the body, is an effective and well-tolerated method of hormone replacement therapy. The Marion Gluck Clinic conducted a small-scale study to assess the effectiveness of compounded bioidentical hormone replacement therapy treatment protocols and their impact on the quality of life of women experiencing symptoms of the menopause. Quality of life was assessed by completing the Greene Climacteric Scale questionnaire before and after bioidentical hormone replacement therapy treatment. Statistical significance of the data was tested using a Student's two-tailed, paired t-test. The results demonstrated a significant improvement of 52% in quality of life after bioidentical hormone replacement therapy treatment. All 21 menopausal symptoms assessed were greatly reduced after BHRT treatment. Evidence is provided showing that bioidentical hormone replacement therapy, performed according to the Marion Gluck Clinic local clinical guidelines, improves quality of life and reduces menopause-associated symptoms in women. In addition, this pilot study paves the way for a future full-scale study, where the authors aim to assess quality of life and safety in a significantly larger number of women.